Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML

被引：0
|
作者：
Thomas Pfeiffer
Ying Li
Emily Ashcraft
Seth E. Karol
Jeffrey E. Rubnitz
Rebecca Epperly
Renee Madden
Ewelina Mamcarz
Esther Obeng
Amr Qudeimat
Akshay Sharma
Ashok Srinivasan
Ali Suliman
Aimee C. Talleur
M. Paulina Velasquez
Stephen Gottschalk
Brandon M. Triplett
Swati Naik
机构：
[1] St. Jude Children’s Research Hospital,Department of Bone Marrow Transplantation and Cellular Therapy
[2] St. Jude Children’s Research Hospital,Department of Biostatistics
[3] St. Jude Children’s Research Hospital,Department of Oncology
来源：
Bone Marrow Transplantation | 2023年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：328 / 331
页数：3
相关论文
共 50 条
  • [1] Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
    Pfeiffer, Thomas
    Li, Ying
    Ashcraft, Emily
    Karol, Seth E.
    Rubnitz, Jeffrey E.
    Epperly, Rebecca
    Madden, Renee
    Mamcarz, Ewelina
    Obeng, Esther
    Qudeimat, Amr
    Sharma, Akshay
    Srinivasan, Ashok
    Suliman, Ali
    Talleur, Aimee C.
    Velasquez, M. Paulina
    Gottschalk, Stephen
    Triplett, Brandon M.
    Naik, Swati
    BONE MARROW TRANSPLANTATION, 2023, 58 (03) : 328 - 331
  • [2] Venetoclax-based combination therapy as a bridge to allogeneic hematopoietic cell transplant in children with relapsed/refractory AML
    Pfeiffer, Thomas
    Li, Ying
    Karol, Seth E.
    Rubnitz, Jeffrey E.
    Epperly, Rebecca
    Madden, Renee
    Mamcarz, Ewelina
    Obeng, Esther A.
    Qudeimat, Amr
    Sharma, Akshay
    Srinivasan, Ashok
    Suliman, Ali
    Talleur, Aimee C.
    Velasquez, Mireya Paulina
    Gottschalk, Stephen
    Triplett, Brandon M.
    Naik, Swati
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [3] Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
    Joshi, Maansi
    Cook, Joselle
    McCullough, Kristen
    Nanaa, Ahmad
    Gangat, Naseema
    Foran, James M.
    Murthy, Hemant S.
    Kharfan-Dabaja, Mohamed A.
    Sproat, Lisa
    Palmer, Jeanne
    Pardanani, Animesh
    Tefferi, Ayalew
    Begna, Kebede
    Elliot, Michelle
    Al-Kali, Aref
    Patnaik, Mrinal
    Shah, Mithun V.
    Hogan, William J.
    Litzow, Mark R.
    Alkhateeb, Hassan B.
    BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [4] Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
    Maansi Joshi
    Joselle Cook
    Kristen McCullough
    Ahmad Nanaa
    Naseema Gangat
    James M. Foran
    Hemant S. Murthy
    Mohamed A. Kharfan-Dabaja
    Lisa Sproat
    Jeanne Palmer
    Animesh Pardanani
    Ayalew Tefferi
    Kebede Begna
    Michelle Elliot
    Aref Al-Kali
    Mrinal Patnaik
    Mithun V. Shah
    William J. Hogan
    Mark R. Litzow
    Hassan B. Alkhateeb
    Blood Cancer Journal, 11
  • [5] Salvage use of venetoclax-based Therapy for Relapsed AML Post Allogeneic Hematopoietic Stem Cell Transplant
    Cook, Joselle
    Joshi, Maansi
    Gangat, Naseema
    Pardanani, Animesh
    Tefferi, Ayalew
    Begna, Kebede
    Elliot, Michelle
    Al-Kali, Aref
    Patnaik, Mrinal
    Shah, Mithun V.
    Hogan, William J.
    Litzow, Mark
    Alkhateeb, Hassan B.
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 191 - 191
  • [6] Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients
    Yang, Ting-Ting
    Song, Xiao-Lu
    Zhao, Yan-Min
    Ye, Bao-Dong
    Luo, Yi
    Xiao, Hao-Wen
    Chen, Yi
    Fu, Hua-Rui
    Yu, Jian
    Liu, Li-Zhen
    Lai, Xiao-Yu
    Ye, Yi-Shan
    Lan, Jian-Ping
    Huang, He
    Shi, Ji-Min
    ANNALS OF HEMATOLOGY, 2022, 101 (12) : 2731 - 2741
  • [7] Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients
    Ting-Ting Yang
    Xiao-Lu Song
    Yan-Min Zhao
    Bao-Dong Ye
    Yi Luo
    Hao-Wen Xiao
    Yi Chen
    Hua-Rui Fu
    Jian Yu
    Li-Zhen Liu
    Xiao-Yu Lai
    Yi-shan Ye
    Jian-Ping Lan
    He Huang
    Ji-Min Shi
    Annals of Hematology, 2022, 101 : 2731 - 2741
  • [8] Venetoclax-Based Therapy before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
    Kato, Chika
    Najima, Yuho
    Sadato, Daichi
    Hirama, Chizuko
    Kato, Kana
    Kondo, Kaori
    Sadaga, Yasutaka
    Sakai, Satoshi
    Kambara, Yasuhiro
    Nabe, Yoshimi
    Teshima, Ko
    Asano, Kazuya
    Kurihara, Kazuya
    Jinguji, Atsushi
    Shimabukuro, Masashi
    Ouchi, Fumihiko
    Inai, Kazuki
    Koi, Satoshi
    Shingai, Naoki
    Toya, Takashi
    Shimizu, Hiroaki
    Haraguchi, Kyoko
    Kobayashi, Takeshi
    Harada, Hironori
    Okuyama, Yoshiki
    Harada, Yuka
    Doki, Noriko
    BLOOD, 2023, 142
  • [9] Comparison of Two Venetoclax-Based Regimens As Salvage Therapies Bridged to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Ye, Yiling
    Chen, Yanqiu
    Yu, Guopan
    Weng, Guangyang
    Liu, Qifa
    Jin, Hua
    BLOOD, 2023, 142
  • [10] Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML - Interim Results of the Bridge Trial
    Middeke, Jan Moritz
    Parmentier, Stefani
    Alakel, Nael
    Schaich, Markus
    Thiede, Christian
    Platzbecker, Uwe
    Roellig, Christoph
    Haenel, Mathias
    Stuhler, Gernot
    Morgner, Anke
    Eulenstein, Uta
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Schetelig, Johannes
    BLOOD, 2012, 120 (21)
12345